EGFR and colon carcinoma: To address this hypothesis, we compared TIL and paired PBMC function, by analyzing NK cell IFNγ production and degranulation activity in the presence of the MHC class I non-expressing K562 cells or with EGFR+ SW480 colon carcinoma target cells in the presence of Cetuximab in an ADCC assay.